Literature DB >> 3014109

Diurnal variations of benzodiazepine binding in rat cerebral cortex: disruption by pinealectomy.

D Acuña-Castroviejo, P R Lowenstein, R Rosenstein, D P Cardinali.   

Abstract

In a previous work, pinealectomy was found to depress benzodiazepine (BZP) receptor binding in cerebral cortex membranes of rats killed at noon. In order to assess the effect of pineal removal on diurnal variations of BZP binding site concentration and affinity, groups of intact, pinealectomized, or sham-pinealectomized rats (subjected to surgery 2 wk earlier) were killed at six different time intervals during the 24-h cycle. BZP binding was assessed by Scatchard analysis of 3H-flunitrazepam high-affinity binding to cerebral cortex membranes. In intact and sham-pinealectomized rats, a maximum in BZP receptor concentration was found at midnight. Pinealectomy blunted the nocturnal peak of receptor concentration and caused a significant depression of binding site number at noon. No changes in the affinity of the binding sites for the radioligand were detected as a function of time of day or following surgery. In a dose-response experiment for melatonin ability to restore the depressed BZP receptor concentration of cerebral cortex membranes of pinealectomized rats killed at noon, a minimal effective dose of 25 micrograms/kg body weight was obtained. These results further support a link between pineal activity and brain BZP receptors in rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014109     DOI: 10.1111/j.1600-079x.1986.tb00732.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  9 in total

Review 1.  The rhythmic GABAergic system.

Authors:  D P Cardinali; D A Golombek
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  Pineal response after pyridoxine test in children.

Authors:  A Muñoz-Hoyos; I Amorós-Rodríguez; A Molina-Carballo; J Uberos-Fernández; D Acuña-Castroviejo
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  The Zebrafish, an Outstanding Model for Biomedical Research in the Field of Melatonin and Human Diseases.

Authors:  Paula Aranda-Martínez; José Fernández-Martínez; Yolanda Ramírez-Casas; Ana Guerra-Librero; César Rodríguez-Santana; Germaine Escames; Darío Acuña-Castroviejo
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

4.  Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.

Authors:  Yulin Sun; Weiwei Feng; Jian Chen; Miao Liu; Xiuyu Shi; Jing Wang; Liping Zou; Tao Xu; Guang Yang
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

Review 5.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

6.  Participation of ACTH1-10 and ACTH4-10 on the melatonin modulation of benzodiazepine receptors in rat cerebral cortex.

Authors:  M D Gomar; B Fernández; C M Del Aguila; J L Castillo; G Escames; D Acuña-Castroviejo
Journal:  Experientia       Date:  1995-03-15

Review 7.  Melatonin as add-on treatment for epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Alessandra Del Felice
Journal:  Cochrane Database Syst Rev       Date:  2016-08-11

Review 8.  Melatonin: A Versatile Protector against Oxidative DNA Damage.

Authors:  Annia Galano; Dun-Xian Tan; Russel J Reiter
Journal:  Molecules       Date:  2018-02-27       Impact factor: 4.411

Review 9.  Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression.

Authors:  Eunsoo Won; Kyoung-Sae Na; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.